Life Sciences AI and Analytics Services for Commercial – Provider Compendium 2025

In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need for innovative, patient-focused commercialization strategies for drugs and devices. Simultaneously, rising expectations for customer experience have driven greater reliance on specialized providers. These providers are leveraging generative AI, advanced analytics, and machine learning to streamline operations and boost efficiency. In line with enterprise needs, they are expanding their offerings into holistic, end-to-end solutions that support both pre-launch planning and post-launch execution across commercialization activities.

In this report, we assess 19 providers featured in the Life Sciences AI and Analytics Services for Commercial PEAK Matrix^® report. It enables buyers to choose the best-fit provider based on their sourcing considerations and empowers providers to benchmark themselves against their peers.